Conserved signaling pathways underlying heterotopic ossification
- PMID: 28455214
- PMCID: PMC5801212
- DOI: 10.1016/j.bone.2017.04.014
Conserved signaling pathways underlying heterotopic ossification
Erratum in
-
Corrigendum to 'Conserved signaling pathways underlying heterotopic ossification' [Bone, 109, April 2018, 43-48].Bone. 2019 May;122:254. doi: 10.1016/j.bone.2019.02.023. Epub 2019 Feb 28. Bone. 2019. PMID: 30826307 No abstract available.
Abstract
Heterotopic ossification (HO), a serious disorder of extra-skeletal bone formation, occurs as a common complication of trauma or in rare genetic disorders. Many conserved signaling pathways have been implicated in HO; however, the exact underlying molecular mechanisms for many forms of HO are still unclear. The emerging picture is that dysregulation of bone morphogenetic protein (BMP) signaling plays a central role in the process, but that other conserved signaling pathways, such as Hedgehog (HH), Wnt/β-catenin and Fibroblast growth factors (FGF), are also involved, either through cross-talk with BMP signaling or through other independent mechanisms. Deep understanding of the conserved signaling pathways is necessary for the effective prevention and treatment of HO. In this review, we update and integrate recent progress in this area. Hopefully, our discussion will point to novel promising, druggable loci for further translational research and successful clinical applications.
Keywords: Bone morphogenetic protein (BMP); Conserved signaling pathways; Fibroblast growth factor (FGF); Fibrodysplasia ossificans progressiva (FOP); Hedgehog (HH); Heterotopic ossification (HO); Transforming growth factor β (TGF-β); Wnt/β-catenin.
Copyright © 2017 Elsevier Inc. All rights reserved.
Figures
References
-
- Forsberg JA. Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors. J Bone Joint Surg. 2009;91:1084–1091. - PubMed
-
- Shore EM. Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N Engl J Med. 2002;346:99–106. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
